Alpha Tau Medical
With more than 20 years of top leadership and executive roles in various fields, Mr. Segal brings a multi-disciplinary technological and managerial background. He served in a variety of senior managerial and development positions, including CTO, Deputy CEO & Head of BD. In addition, Mr. Segal headed several significant technological projects at MAFAT (Ministry of defence R&D division) and the Navy Submarines project.
This person is not in any offices
Alpha Tau Medical
Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide.